CommercialCoverageMedium impact
Implantable Cardioverter Defibrillator (ICD) - (Effective Date - 2026-06-15) 7.01.06
Excellus BlueCross BlueShield·Cardiology, Cardiothoracic Surgery·Heart & Blood Vessels (Cardiovascular)
Effective date
Jun 15, 2026
We identified it
Jun 20, 2026
Summary
This is a comprehensive new policy from Excellus BlueCross BlueShield defining medical necessity criteria for Implantable Cardioverter Defibrillator (ICD) procedures, effective June 15, 2026. The policy establishes detailed coverage criteria for both primary and secondary prevention of sudden cardiac death across various cardiac conditions including ischemic and non-ischemic cardiomyopathy.
Action Required
Before June 15, 2026: Billing and clinical teams must review and implement new ICD medical necessity criteria for Excellus BlueCross BlueShield claims. Update prior authorization processes to ensure documentation meets specific LVEF thresholds, NYHA class requirements, and timing criteria outlined in the policy. Train providers on detailed coverage requirements for primary and secondary prevention indications to prevent claim denials.